Chromoanagenesis in Multiple Myeloma: A Comprehensive Overview

Area of Science:

• Genomics
• Cancer Biology
• Molecular Oncology

Background:

• Chromoanagenesis, encompassing chromothripsis, chromoplexy, and chromoanasynthesis, is implicated in cancer development.
• In multiple myeloma (MM), chromothripsis is linked to poor prognosis, while chromoplexy is not; chromoanasynthesis is less defined in MM.
• Chromothripsis may be a driver event in MM, predicting progression from precursor to symptomatic disease.

Purpose of the Study:

• To review the history of complex genomic alteration detection in MM.
• To highlight the evolution and laxity in definitions of chromoanagenesis.
• To emphasize the need for consensus criteria for precise MM investigation.

Main Methods:

• Review of historical data and current literature on chromoanagenesis detection in MM.
• Discussion of whole genome sequencing as the gold standard.
• Introduction of alternative techniques like optical genome mapping and long-read sequencing.

Main Results:

• Historical definitions of chromoanagenesis have become less precise, potentially losing critical information.
• Whole genome sequencing, optical genome mapping, and long-read sequencing are key for detecting complex genomic events.
• Clearer definitions are needed to differentiate between chromothripsis, chromoplexy, and chromoanasynthesis in MM.

Conclusions:

• Establishing consensus-based criteria for chromoanagenesis is essential for accurate MM research.
• Understanding chromothripsis in MM offers insights into pathogenesis and potential therapeutic targets.
• Targeting chromothripsis-induced damage or instability could improve MM patient outcomes.